Back

microRNA-17-5p and microRNA-20a-5p downregulation by atorvastatin in Hepg2 cells: a new mechanism involved in the lipid-lowering therapy

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Mechanisms underlying pharmacotherapy Lipid-Lowering Agents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Kathleen Saavedra

University of La Frontera, Temuco (Chile)

6 More presentations in this session

Presentation thumbnail
Doctor P. Nikolaou (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor O. Perez-Mendez (Mexico City, MX)
Abstract Slides
Presentation thumbnail
Miss T. Kasi Ganeshan (London, GB)
Abstract
Presentation thumbnail
Miss C. Almenglo (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor C. del Rio (Brisbane, US)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Mechanisms underlying pharmacotherapy

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources